Manufacturer of Recalled ASR Hip Implant to Pay ₹10 Lakh for Patient's Suffering, Surgeon Exonerated

CHENNAI: The Tamil Nadu State Consumer Disputes Redressal Commission has ordered Depuy Synthes, a subsidiary of Johnson & Johnson, to pay ₹10 lakh in compensation to a patient who suffered due to a faulty "metal-on-metal" ASR hip implant. In a significant ruling, the Commission, presided over by Justice R. Subbiah, absolved the surgeon and the hospital of any medical negligence, holding the manufacturer solely liable for the defective device.

The Commission also clarified a crucial point on the statute of limitations, stating that for latent defects in medical implants, the cause of action arises when the harm is discovered, not from the date of the surgery.

---

Background of the Case

The complaint was filed by Mr. M. Ameenudeen Alhad, who first underwent a successful hip replacement surgery in 2004 at Ganga Hospital, Coimbatore, performed by Dr. S. Rajasekaran. However, due to the progression of his underlying condition, Ankylosing Spondylitis, he required another surgery on his other hip in 2008.

For this second surgery, Dr. Rajasekaran recommended and implanted the ASR Hip Resurfacing System, manufactured by Depuy Synthes (the second opposite party). Post-surgery, Mr. Alhad began experiencing numerous health issues, including pain, headaches, skin eruptions, and memory loss. Blood tests later revealed elevated levels of chromium and cobalt, metals used in the implant.

Unbeknownst to the patient for several years, the manufacturer had issued a global voluntary recall of the ASR hip implant system in August 2010 due to a higher-than-expected failure rate.

Arguments from Both Sides

Complainant's Arguments: Mr. Alhad's counsel argued that Dr. Rajasekaran was negligent for using a new, "not time-tested" device and for failing to inform him about the global recall in a timely manner. He contended that the surgeon used him as an "experiment model" and did not pay adequate attention to his post-operative complaints. The complainant linked his deteriorating health, including high metal ion levels and thyroid issues, directly to the defective implant.

Opposite Parties' Arguments: Dr. Rajasekaran countered that the ASR implant was a state-of-the-art device, approved by global agencies like the FDA, and widely used at the time of the 2008 surgery. He maintained that he had informed the patient of the device's advantages and had not coerced him. He attributed the patient's symptoms to the natural progression of Ankylosing Spondylitis, not the implant, which appeared stable in X-rays.

The manufacturer, Depuy Synthes, admitted to the voluntary recall but argued that the patient's health issues were likely due to his pre-existing condition. They also contended that the complaint was barred by limitation, as it was filed in 2013, more than two years after the 2010 recall.

Commission's Legal Analysis and Findings

The Commission meticulously analyzed the evidence and arguments, focusing on whether the patient's suffering was a direct result of the ASR implant.

“The fact that the second Opposite Party reimbursed a portion of medical expenses incurred by the complainant itself would show that due to defective ASR Hip Replacement System used in the course of surgery... the complainant was subjected to acute pain and agony for which he has to be compensated.”

The Commission noted that the manufacturer’s voluntary recall and its offer to reimburse patients were critical admissions. It was further reinforced by a letter from Dr. Rajasekaran in 2016, which stated: "As you may have heard, the ASR has now been recalled. This is primarily because of unexpected failure rate in comparison to other implants of the same category in some centers."

Citing a similar case decided by the National Consumer Disputes Redressal Commission ( Mrs. Lalita Rajpurohit vs. M/s. Johnson & Johnson ), the court affirmed that when a defective product causes bodily injury, compensation is warranted under the law of torts.

On the issue of limitation, the Commission relied on precedents from the Supreme Court, holding that for latent defects, the limitation period begins when the harm is discovered. In this case, the complainant became aware of the implant's potential defects and high metal ion levels in 2012, bringing his 2013 complaint within the permissible time frame.

Final Verdict

The Commission concluded that the manufacturer, Depuy Synthes, was liable for the deficiency in service due to its defective product. However, it found no negligence on the part of Dr. S. Rajasekaran, who had used a globally approved device in good faith before any negative reports or the recall became public knowledge.

The final order stated:

"The complainant is entitled for payment of compensation by the second Opposite Party and the first Opposite Party, who is an Orthopedic Surgeon, is not in any manner made liable or responsible for the sufferance endured by the complainant."

The Commission directed the 2nd opposite party, Depuy Synthes, to pay a total of ₹10 lakhs as compensation to Mr. Alhad for his pain, mental agony, and personal discomfort. The amount is to be paid within eight weeks, failing which it will attract an interest of 9% per annum from the date of the complaint.